
Semaglutide’s Long-Term Safety for American Males: Diabetes and Obesity Management
Reading Time: 2 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a pivotal therapeutic option for managing type 2 diabetes and obesity. As its use becomes more widespread among American males, understanding its long-term safety profile is crucial. This article reviews the current evidence on the long-term safety of semaglutide, focusing on its implications for American men. Overview of Semaglutide Semaglutide is administered either subcutaneously or orally and works by mimicking the effects of the incretin hormone, GLP-1. It enhances insulin secretion, suppresses glucagon release, and delays gastric emptying, thereby aiding in glycemic control and weight loss. Given its efficacy,...